FIELD: pharmaceutics.
SUBSTANCE: in the present claim, a solid lyophilized vaginal dosed form is disclosed that can contain the effective amount of acyclovir, a crystal structure-forming agent that is mannitol in the amount of about 5 wt.% to about 40 wt.% per the total weight of the lyophilized dosed form, and at least one substance forming a polymer mucoadhesive matrix. The dosed form can have pH of about 4.0-5.0 and can disintegrate within 120 seconds after it comes into contact with vaginal mucosa. A method for delivering an active ingredient to vaginal mucosa using an open solid dosed form is also described.
EFFECT: obtaining lyophilized pharmaceutical compositions for vaginal delivery.
12 cl, 12 dwg, 12 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ORALLY DISPERSABLE VACCINE CONTAINING VIROSOMES | 2019 |
|
RU2808276C2 |
AGENT FOR INTRAVAGINAL DELIVERY OF ACTIVE COMPONENT, METHOD OF PRODUCTION AND USE OF THE MEDICINAL PRODUCT | 2022 |
|
RU2806114C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING OLIGOMERIC LACTIC ACID | 2013 |
|
RU2627470C2 |
QUICK-SOLUBLE PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2633640C2 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566269C2 |
PROCESS FOR REDUCTION IN ENDOTOXIN CONTENT IN GELATIN | 2019 |
|
RU2788164C2 |
METHOD OF COMPOSING QUICKLY DISPERSED DRUG FORMS, WHICH CONTAIN AT LEAST ONE FISH GELATIN, SELECTED ON MOLECULAR WEIGHT BASIS | 2005 |
|
RU2415665C2 |
SUBLINGUAL OR TRANSBUCCAL PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139051C1 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566270C2 |
QUICK-SOLVING DRUG FORM OF ORAL VACCINE IN WHICH STARCH IS USED | 2011 |
|
RU2639447C2 |
Authors
Dates
2021-08-24—Published
2017-10-13—Filed